EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Vulvovaginal Infections in Saudi Arabia: Prevalence in Clinically Sampled and Screened Populations, Aetiology and Antimicrobial Resistance: A Systematic Review and Meta-Analysis

Yazeed Albalawi, Mohammad Zubair

Antibiotics · 18.11.2026 · 15 (11) · 1152

DOI: 10.3390/antibiotics15111152 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Antibiotics, online erschienen am 18.11.2026. Verfasst von Yazeed Albalawi und 1 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research, Development, and Innovation Authority (RDIA)—Kingdom of Saudi Arabia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vulvovaginal infections are among the commonest reasons women seek gynaecological care, but Saudi estimates come from scattered single-centre studies that differ in population, diagnostic criteria and laboratory method. We set out to synthesise what those studies report about prevalence, causative organisms and antimicrobial susceptibility.

Methods

PubMed/MEDLINE and the Saudi Digital Library were searched using nine numbered Boolean lines combining vulvovaginal condition terms, organism names and Saudi geographic terms, with no date or language restriction. The search was supplemented by hand-searching and citation searching of Saudi and regional journals. The review was registered in PROSPERO (CRD420261569339). Eligible studies reported original data from Saudi Arabia on female genital tract specimens with an extractable denominator. Two outcome streams were kept separate throughout: diagnosed infection and organism colonisation or detection. Study quality was appraised with the nine-item JBI checklist for prevalence studies. Proportions were pooled under a random-effects model after Freeman–Tukey double-arcsine transformation, but only where populations, outcome definitions and denominators were comparable.

Results

Of 288 unique records, 35 were assessed in full text and 21 studies met the eligibility criteria; hand-searching identified two further eligible studies, giving 23 included studies and 147 extracted outcome rows. Group B Streptococcus colonisation in screened pregnant women was 19.0% (95% CI 8.2–32.9; 8 studies, 8793 women), and Candida culture positivity among symptomatic women attending clinical services was 27.4% (95% CI 17.8–38.1; 5 studies, 5353 women). Heterogeneity was extreme in both (I-squared 99.4% and 97.2%), and the prediction intervals span almost the whole plausible range, so neither value should be read as a national figure. Both estimates refer to the clinical or screening population sampled, not to women in Saudi Arabia generally. Repeating the two primary analyses on the logit scale and with a binomial–normal generalised linear mixed model changed little (17.4% and 17.3% for colonisation; 27.1% and 27.0% for Candida). Trichomoniasis was not pooled as a primary outcome because estimates ranged from 0.7% to 15.0%; restricting the analysis to the three studies that state a detection method removed the heterogeneity entirely and gave 13.8% (95% CI 12.3–15.4; I-squared 0%); that restricted figure rests on three studies with different detection methods and recruitment criteria and remains exploratory. Candida albicans predominated in every study reporting species, but accounted for 42.1% to 70.7% of isolates, with C. glabrata consistently second. Reported fluconazole resistance in Candida ranged from 0% to 85% across five studies using three different testing methods. Group B Streptococcus remained fully susceptible to penicillin G, ampicillin and vancomycin in both studies that tested them, 238 isolates in total, while erythromycin resistance was 15.7% and 16.7%.

Conclusions

The Saudi evidence base is dominated by Group B Streptococcus screening in pregnancy and by vulvovaginal candidiasis. Bacterial vaginosis has one study with an extractable denominator and aerobic vaginitis none, which is the clearest gap identified. Pooled values carry wide prediction intervals and heterogeneity that subgroup analysis by region, period, sampling site, sampling frequency and population did not resolve. The resistance evidence is too fragmented to guide empiric therapy, chiefly because breakpoint standards go unreported in more than half of the susceptibility results.

Förderung

  • Research, Development, and Innovation Authority (RDIA)—Kingdom of Saudi Arabia

Zitieren

APA

Albalawi, Y., & Zubair, M. (2026). Vulvovaginal Infections in Saudi Arabia: Prevalence in Clinically Sampled and Screened Populations, Aetiology and Antimicrobial Resistance: A Systematic Review and Meta-Analysis. Antibiotics, 15(11), 1152. https://doi.org/10.3390/antibiotics15111152

Vancouver

Albalawi Y, Zubair M. Vulvovaginal Infections in Saudi Arabia: Prevalence in Clinically Sampled and Screened Populations, Aetiology and Antimicrobial Resistance: A Systematic Review and Meta-Analysis. Antibiotics. 2026;15(11):1152. doi:10.3390/antibiotics15111152

BibTeX
@article{Albalawi2026,
  author = {Albalawi, Yazeed and Zubair, Mohammad},
  title = {Vulvovaginal Infections in Saudi Arabia: Prevalence in Clinically Sampled and Screened Populations, Aetiology and Antimicrobial Resistance: A Systematic Review and Meta-Analysis},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1152},
  doi = {10.3390/antibiotics15111152}
}
Kostenlos starten →